DK162518C - Fremgangsmaade til fremstilling af en stabil modifikation af torasemid, samt et farmaceutisk praeparat indeholdende denne - Google Patents
Fremgangsmaade til fremstilling af en stabil modifikation af torasemid, samt et farmaceutisk praeparat indeholdende denneInfo
- Publication number
- DK162518C DK162518C DK385586A DK385586A DK162518C DK 162518 C DK162518 C DK 162518C DK 385586 A DK385586 A DK 385586A DK 385586 A DK385586 A DK 385586A DK 162518 C DK162518 C DK 162518C
- Authority
- DK
- Denmark
- Prior art keywords
- torasemide
- preparing
- procedure
- pharmaceutical preparation
- preparation containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19853529529 DE3529529A1 (de) | 1985-08-17 | 1985-08-17 | Verfahren zur herstellung einer stabilen modifikation von torasemid |
| DE3529529 | 1985-08-17 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| DK385586D0 DK385586D0 (da) | 1986-08-13 |
| DK385586A DK385586A (da) | 1987-02-18 |
| DK162518B DK162518B (da) | 1991-11-11 |
| DK162518C true DK162518C (da) | 1992-03-30 |
Family
ID=6278766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK385586A DK162518C (da) | 1985-08-17 | 1986-08-13 | Fremgangsmaade til fremstilling af en stabil modifikation af torasemid, samt et farmaceutisk praeparat indeholdende denne |
Country Status (25)
| Country | Link |
|---|---|
| US (4) | US4743693A (fi) |
| EP (1) | EP0212537B1 (fi) |
| JP (2) | JPS6245576A (fi) |
| KR (1) | KR930009818B1 (fi) |
| AU (1) | AU573454B2 (fi) |
| CA (1) | CA1307277C (fi) |
| CS (2) | CS259891B2 (fi) |
| DD (1) | DD259858A5 (fi) |
| DE (2) | DE3529529A1 (fi) |
| DK (1) | DK162518C (fi) |
| ES (1) | ES2001522A6 (fi) |
| FI (1) | FI82189C (fi) |
| GR (1) | GR862139B (fi) |
| HK (1) | HK59994A (fi) |
| HU (1) | HU195778B (fi) |
| IE (1) | IE59237B1 (fi) |
| IL (1) | IL79672A (fi) |
| LT (1) | LT3596B (fi) |
| NO (1) | NO170079C (fi) |
| NZ (1) | NZ217172A (fi) |
| PL (1) | PL146086B1 (fi) |
| PT (1) | PT83186B (fi) |
| SU (1) | SU1480766A3 (fi) |
| UA (1) | UA7080A1 (fi) |
| ZA (1) | ZA866151B (fi) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3623620A1 (de) * | 1986-07-12 | 1988-01-21 | Boehringer Mannheim Gmbh | Spritzfertige, waessrige, alkalische injektionsloesungen von torasemid und verfahren zu ihrer herstellung |
| US5166162A (en) * | 1990-03-02 | 1992-11-24 | Adir Et Compagnie | Pyridylsulfonylurea and pyridylsulfonylthiourea compounds |
| JP3586471B2 (ja) * | 1991-06-25 | 2004-11-10 | 三菱ウェルファーマ株式会社 | トラセミド含有医薬組成物 |
| HRP980532B1 (en) * | 1998-10-02 | 2005-06-30 | Pliva | Novel crystalline torasemide modification |
| US6166045A (en) | 1998-06-02 | 2000-12-26 | Roche Diagnostics Gmbh | Torasemide of modification III |
| US5914336A (en) | 1998-06-02 | 1999-06-22 | Boehringer Mannheim Gmbh | Method of controlling the serum solubility of orally administered torasemide and composition relating thereto |
| US20030026835A1 (en) * | 1999-02-15 | 2003-02-06 | Sumitomo Pharmaceuticals Company Limited | Tablets disintegrating rapidly in the oral cavity |
| US6465496B1 (en) * | 1999-08-11 | 2002-10-15 | Teva Pharmaceutical Industries, Ltd. | Torsemide polymorphs |
| MXPA03007908A (es) * | 2000-02-17 | 2004-12-06 | Teva Pharma | Una formulacion farmaceutica estable que comprende una modificacion de torsemida ii. |
| HRP20000162B1 (en) * | 2000-03-20 | 2004-06-30 | Pliva D D | Amorphous torasemide modification |
| CA2403382A1 (en) | 2000-03-20 | 2001-09-27 | Teva Pharmaceutical Industries Ltd. | Novel processes for preparing torsemide intermediate |
| HRP20000765A2 (en) * | 2000-11-10 | 2002-06-30 | Pliva D D | Compositions of n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides with increased release |
| US20030022921A1 (en) * | 2001-02-21 | 2003-01-30 | Minutza Leibovici | Stable pharmaceutical formulation comprising torsemide modification II |
| IN192178B (fi) * | 2001-08-03 | 2004-03-06 | Ranbaxy Lab | |
| EP2316468A1 (en) | 2002-02-22 | 2011-05-04 | Shire LLC | Delivery system and methods for protecting and administering dextroamphetamine |
| ITMI20020639A1 (it) * | 2002-03-27 | 2003-09-29 | Cosma S P A | Composizioni farmaceutiche comprendenti come principio attivo 1-isopropil-3°(4-m-toluidino-3-pridil)sulfonil!-urea |
| HRP20020603B1 (en) * | 2002-07-19 | 2008-11-30 | Pliva D.D. | New process for the preparation of modification i n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridinesulfonamide |
| US7683080B2 (en) * | 2002-11-18 | 2010-03-23 | Teva Pharmaceutical Industries Ltd. | Stable iansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol |
| CA2515130A1 (en) * | 2003-02-05 | 2004-08-26 | Teva Pharmaceutical Industries Ltd. | Method of stabilizing lansoprazole |
| ES2244324B1 (es) * | 2004-03-25 | 2006-11-16 | Ferrer Internacional, S.A. | Composiciones diureticas de liberacion prolongada. |
| AT500576B1 (de) * | 2004-07-28 | 2006-11-15 | Sanochemia Pharmazeutika Ag | Verfahren zur reindarstellung von kristallformen von torsemid |
| US10178893B1 (en) * | 2013-06-14 | 2019-01-15 | Scott Bradley Baker | Shoe |
| FR3018688A1 (fr) * | 2014-03-19 | 2015-09-25 | Virbac | Utilisation de torasemide a faible dose dans une composition veterinaire |
| EP3031471A1 (en) | 2014-12-12 | 2016-06-15 | Ceva Sante Animale | Veterinary composition for the treatment of pulmonary edema associated with heart failure in domestic animals |
| SI3173075T1 (sl) * | 2015-11-27 | 2019-02-28 | Accupharma Spolka Z Ograniczona Odpowiedzialnoscia | Farmacevtski kombinacijski pripravek inhibitorja ACE in diuretika zanke |
| CN115417810B (zh) * | 2022-09-22 | 2023-10-10 | 南京正科医药股份有限公司 | 一种托拉塞米晶型ⅰ的精制方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US30633A (en) * | 1860-11-13 | Improvement in fire-escapes | ||
| GB1477664A (en) * | 1974-04-17 | 1977-06-22 | Christiaens Sa A | Pyridine derivatives |
| GB1593609A (en) * | 1978-01-31 | 1981-07-22 | Christiaens Sa A | Pyridine sulfonamides |
| LU85193A1 (fr) * | 1984-01-31 | 1985-09-12 | Christiaens Sa A | Nouveaux derives de la 4-phenylaminopyridine,leur utilisation et leur preparation |
-
1985
- 1985-08-17 DE DE19853529529 patent/DE3529529A1/de active Granted
-
1986
- 1986-08-10 IL IL79672A patent/IL79672A/xx not_active IP Right Cessation
- 1986-08-11 AU AU61055/86A patent/AU573454B2/en not_active Expired
- 1986-08-11 US US06/895,355 patent/US4743693A/en not_active Ceased
- 1986-08-11 CS CS865945A patent/CS259891B2/cs not_active IP Right Cessation
- 1986-08-11 CA CA000515676A patent/CA1307277C/en not_active Expired - Lifetime
- 1986-08-12 NZ NZ217172A patent/NZ217172A/xx unknown
- 1986-08-12 PT PT83186A patent/PT83186B/pt unknown
- 1986-08-12 EP EP86111118A patent/EP0212537B1/de not_active Expired - Lifetime
- 1986-08-12 DE DE8686111118T patent/DE3667970D1/de not_active Expired - Lifetime
- 1986-08-13 DK DK385586A patent/DK162518C/da not_active IP Right Cessation
- 1986-08-13 IE IE217986A patent/IE59237B1/en not_active IP Right Cessation
- 1986-08-14 DD DD86293655A patent/DD259858A5/de not_active IP Right Cessation
- 1986-08-14 KR KR1019860006689A patent/KR930009818B1/ko not_active IP Right Cessation
- 1986-08-14 ES ES8601131A patent/ES2001522A6/es not_active Expired
- 1986-08-14 GR GR862139A patent/GR862139B/el unknown
- 1986-08-15 FI FI863305A patent/FI82189C/fi not_active IP Right Cessation
- 1986-08-15 PL PL1986261052A patent/PL146086B1/pl unknown
- 1986-08-15 HU HU863598A patent/HU195778B/hu unknown
- 1986-08-15 SU SU864027953A patent/SU1480766A3/ru active
- 1986-08-15 ZA ZA866151A patent/ZA866151B/xx unknown
- 1986-08-15 UA UA4027953A patent/UA7080A1/uk unknown
- 1986-08-15 NO NO863305A patent/NO170079C/no not_active IP Right Cessation
- 1986-08-18 JP JP61191789A patent/JPS6245576A/ja active Granted
-
1987
- 1987-10-20 US US07/111,439 patent/US4822807A/en not_active Ceased
-
1989
- 1989-10-27 JP JP1278800A patent/JPH0643400B2/ja not_active Expired - Lifetime
-
1991
- 1991-12-31 CS CS914199A patent/CS419991A3/cs unknown
-
1992
- 1992-12-03 US US07/985,053 patent/USRE34580E/en not_active Expired - Lifetime
-
1993
- 1993-04-08 US US08/043,631 patent/USRE34672E/en not_active Expired - Lifetime
- 1993-08-27 LT LTIP898A patent/LT3596B/lt not_active IP Right Cessation
-
1994
- 1994-06-23 HK HK59994A patent/HK59994A/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK162518C (da) | Fremgangsmaade til fremstilling af en stabil modifikation af torasemid, samt et farmaceutisk praeparat indeholdende denne | |
| DK165594C (da) | (-)-benzhydrylsulfinylacetamid, fremgangsmaade til fremstilling heraf, terapeutisk praeparat indeholdende denne forbindelse, samt anvendelse af forbindelsen til fremstilling af et laegemiddel | |
| DK164868C (da) | Imidazooe4,5-baaquinolin-2-on-derivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse | |
| DK407588D0 (da) | Oxadiazolforbindelse, farmaceutisk praeparat indeholdende en saadan forbindelse, anvendelse af forbindelsen til fremstilling af et laegemiddel samt fremgangsmaade til fremstilling af en saadan forbindelse | |
| DK161709C (da) | 13-alkyl-11beta-phenylgonaner, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende dem samt deres anvendelse til fremstilling af laegemidler | |
| DK160985C (da) | Asymmetriske diestere af 1,4-dihydro-2,6-dimethyl-pyridin-3,5-dicarboxylsyre, fremgangsmaader til fremstilling heraf samt farmaceutiske praeparater indeholdende disse | |
| DK163991C (da) | Dichloranilinderivater, fremgangsmaade til fremstilling af disse, samt farmaceutiske praeparater indeholdende derivaterne | |
| DK610988A (da) | Polypeptider, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater der indeholder dem samt anvendelse deraf til fremstilling af et laegemiddel | |
| DK181586A (da) | 2,5-diaryltetrahydrofuran, farmaceutisk praeparat indeholdendeen saadan forbindelse og fremgangsmaade til fremstilling af en saadan forbindelse | |
| DK526586A (da) | Tetraalkylethenylidenbisphosphonater, fremgangsmaade til fremstilling af disse samt farmaceutisk sammensaetning indeholdende samme | |
| DK83386A (da) | Disaccharid- og trisaccharid-derivater af ''lipid a''-typen, praeparater der indeholder disse samt fremgangsmaade til fremstilling af disse | |
| DK164149C (da) | Fremgangsmaade til fremstilling af et praeparat indeholdende methylhydroxyprogesteronacetat samt farmaceutisk praeparat indeholdende stoffet | |
| DK342187A (da) | 4-pyridin-derivater, fremgangsmaade til fremstilling af saadanne derivater samt farmaceutiske praeparater indeholdende disse | |
| DK573386A (da) | Laegemiddel indeholdende en ekstrakt af planter af slaegten caesalpinia samt fremgangsmaade til fremstilling af et saadant laegemiddel | |
| DK66086D0 (da) | Dihydropyridiner, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse | |
| DK60486D0 (da) | Derivater af 2-(4,5-dihydro-2-1h-imidazolyl)-2,3-dihydroindol, fremgangsmaade til fremstilling af samt laegemiddel indeholdende saadannederivater | |
| DK191086D0 (da) | Benzisoselenazolonylderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse | |
| DK163512C (da) | Substituerede azacyclohexylderivater af rifamyciner og salte deraf, farmaceutiske praeparater indeholdende disse forbindelser samt en fremgangsmaade til fremstilling af forbindelserne | |
| DK553689D0 (da) | Phenyloxypropanolaminderivater, fremgangsmaade til fremstilling af saadanne forbindelser samt laegemiddel indeholdende disse | |
| DK63786D0 (da) | Aromatiske alkanderivater, skadedyrsbekaempelsesmidler indeholdende disse forbindelser samt fremgangsmaade til deres fremstilling | |
| DK645988A (da) | Biphenylderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeprater indeholdende samme | |
| DK65986A (da) | Dihydropyridiner, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse | |
| DK561787A (da) | Thiadiazol-derivat, fremgangsmaade til fremstilling af dette, farmaceutisk praeparat indeholdende dette samt anvendelse af dette til fremstilling af et laegemiddel | |
| DK65686A (da) | Dihydropyridiner, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende disse | |
| DK369088D0 (da) | Fremgangsmaade til fremstilling af nukleinsyrederivater og fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende disse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUP | Patent expired |